Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers

Stopped early · Not applicable

Conditions studied: Cancer

In brief

The purpose of this study is to see if mifepristone prevents worsening of your cancer. Mifepristone is an antiprogesterone agent, a drug which blocks female hormones, that is commonly used for the termination of pregnancies. It has not been approved by the Food and Drug Administration for use in the treatment of cancer. It is unlicensed in the United States for your condition. However, previous work has indicated that mifepristone may be useful due to how it works. It is being made available for use in the United States for compassionate use through the Feminist Majority Foundation.

Key facts

Study ID

NCT00832871

Run by

New Mexico Cancer Research Alliance

People needed

4

Starts

2008-11-01

Expected to finish

2015-12-01

Last updated by the study team

2018-06-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients 18 years of age or older.
• Patients must sign an informed consent.
• Patients should be in such a health condition in the opinion of the attending physician that with the administration of mifepristone benefits may outweigh risks.

You may not qualify if…

• Pregnant women or nursing mothers are not eligible for this trial. Patients of child bearing potential must use adequate contraception.

Where it is running

• Universtiy of New Mexico - Cancer Center — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.